Five factors and three characteristics of coronary in-stent restenosis

Nobuaki Suzuki1

  • 1Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan.

Insights

Drug-eluting stent (DES) implantation outcomes can be poor for some patients. In-stent restenosis (ISR) depends on lesion characteristics and patient factors, necessitating tailored strategies to reduce revascularization needs.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Research
  • Medical Device Technology

Background:

  • Drug-eluting stents (DES) are widely used but can lead to suboptimal outcomes in specific patient groups.
  • In-stent restenosis (ISR) remains a significant challenge, impacting clinical and angiographic results post-DES implantation.
  • Understanding the multifactorial nature of ISR is crucial for improving patient management.

Purpose of the Study:

  • To analyze the contributing factors and characteristics of in-stent restenosis (ISR) after drug-eluting stent (DES) implantation.
  • To advocate for personalized treatment strategies based on individual ISR lesion profiles.
  • To reduce the need for further revascularization procedures in patients with ISR.

Main Methods:

  • This editorial comment synthesizes existing knowledge on ISR following DES implantation.
  • It categorizes ISR based on lesion severity, extent, and tissue characteristics.
  • It identifies five key etiological factors: device, patient, anatomy, procedure, and history.

Main Results:

  • In-stent restenosis (ISR) is characterized by the severity and extent of stenosis, along with specific tissue characteristics.
  • ISR is influenced by a combination of five factors: device, patient, anatomy, procedure, and patient history.
  • These factors collectively contribute to the development and presentation of ISR.

Conclusions:

  • A comprehensive understanding of ISR's characteristics and causative factors is essential for effective management.
  • Tailored, individualized strategies are recommended to address the specific profile of each ISR lesion.
  • Implementing personalized approaches holds the potential to minimize the requirement for repeat revascularization procedures.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
948
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
398
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
570
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
695
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
839